We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

127 hedge funds and large institutions have $783M invested in Arcturus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 28

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

64% more call options, than puts

Call options by funds: $27M | Put options by funds: $16.5M

29% more capital invested

Capital invested by funds: $606M → $783M (+$177M)

11.48% more ownership

Funds ownership: 63.2% → 74.68% (+11%)

11% more funds holding

Funds holding: 114 → 127 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
127
Holders Change
+13
Holders Change %
+11.4%
% of All Funds
2.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
33
Increased
54
Reduced
28
Closed
20
Calls
$27M
Puts
$16.5M
Net Calls
+$10.6M
Net Calls Change
+$14.5M

Top Buyers

1
HM
HealthCor Management
New York
+$74.5M
2
State Street
State Street
Massachusetts
+$64.6M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$37.8M
4
AIM
ARK Investment Management
Florida
+$28.6M
5
O
OrbiMed
New York
+$18.8M

Top Sellers

1
Deutsche Bank
Deutsche Bank
Germany
-$25.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$19.3M
3
Invesco
Invesco
Georgia
-$10.5M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$10.4M
5
CH
CVI Holdings
Delaware
-$9.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
ARK Investment Management
Florida
$107M +$28.6M +577,007 +30%
HM
2
HealthCor Management
New York
$68.4M +$74.5M +1,500,252 +1,593%
State Street
3
State Street
Massachusetts
$66.9M +$64.6M +1,302,232 +505%
Federated Hermes
4
Federated Hermes
Pennsylvania
$59.1M +$37.8M +761,631 +124%
BlackRock
5
BlackRock
New York
$49.9M +$9.87M +198,866 +21%
Vanguard Group
6
Vanguard Group
Pennsylvania
$44.5M +$8.25M +166,242 +19%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$33M +$4.72M +95,000 +14%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$30.2M +$9.21M +185,549 +36%
CAM
9
Cormorant Asset Management
Massachusetts
$30M -$4.96M -100,000 -13%
O
10
OrbiMed
New York
$26.5M +$18.8M +379,400 +159%
Janus Henderson Group
11
Janus Henderson Group
United Kingdom
$20.7M +$16.7M +337,270 +231%
Goldman Sachs
12
Goldman Sachs
New York
$18.5M +$17.4M +351,286 +441%
EARNEST Partners
13
EARNEST Partners
Georgia
$13.9M +$2.64M +53,206 +20%
Citadel Advisors
14
Citadel Advisors
Florida
$13.3M -$19.3M -388,035 -56%
Two Sigma Investments
15
Two Sigma Investments
New York
$11.9M +$9.11M +183,572 +198%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$11.6M +$2.85M +57,333 +27%
RI
17
RTW Investments
New York
$10.8M +$12.5M +251,236 New
Northern Trust
18
Northern Trust
Illinois
$10.4M +$1.39M +27,992 +13%
DCM
19
DAFNA Capital Management
California
$9.85M +$4M +80,635 +54%
DI
20
DFPG Investments
Utah
$9.36M -$1.04M -20,870 -10%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$8.39M +$4.82M +97,053 +99%
SSA
22
Schonfeld Strategic Advisors
New York
$7.05M +$7.19M +144,933 +746%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$6.77M +$2.41M +48,600 +44%
Jane Street
24
Jane Street
New York
$6.59M +$3.25M +65,468 +74%
Bank Julius Baer & Co
25
Bank Julius Baer & Co
Switzerland
$5.9M +$6.71M +135,268 New
1
2 3 4 5

ARCT Hedge Fund Activity: Q3 2020 in Review

127 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q3 2020, worth a combined $783M — up 29% from $606M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ARCT positions and 20 closed out — a net gain of 13 holders — while 54 added to existing stakes and 28 trimmed.

The largest buyer was HealthCor Management, adding an estimated $74.5M. The largest seller was Deutsche Bank, cutting an estimated $25.4M.

  • 127 institutional investors held Arcturus Therapeutics (ARCT) as of Q3 2020, up from 114 in Q2 2020.
  • Funds reported $783M of Arcturus Therapeutics stock for Q3 2020, up 29% quarter-over-quarter.
  • 33 funds opened new Arcturus Therapeutics positions in Q3 2020 and 20 closed out, a net change of +13 holders.
  • The largest Arcturus Therapeutics buyer in Q3 2020 was HealthCor Management, an estimated $74.5M added.
  • The largest Arcturus Therapeutics seller in Q3 2020 was Deutsche Bank, an estimated $25.4M sold.

Based on aggregated 13F filings for Q3 2020.